These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 20655748

  • 1. Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents.
    Park CM, Kim SY, Park WK, Choi JH, Seong CM.
    Bioorg Med Chem Lett; 2010 Sep 01; 20(17):5221-4. PubMed ID: 20655748
    [Abstract] [Full Text] [Related]

  • 2. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P, Marciniec K, Maślankiewicz A, Satała G, Duszyńska B, Bojarski AJ, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Pawłowski M.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1545-56. PubMed ID: 22277589
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
    Zajdel P, Marciniec K, Maślankiewicz A, Grychowska K, Satała G, Duszyńska B, Lenda T, Siwek A, Nowak G, Partyka A, Wróbel D, Jastrzębska-Więsek M, Bojarski AJ, Wesołowska A, Pawłowski M.
    Eur J Med Chem; 2013 Feb 15; 60():42-50. PubMed ID: 23279866
    [Abstract] [Full Text] [Related]

  • 4. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.
    Yoo E, Yoon J, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1665-75. PubMed ID: 20096593
    [Abstract] [Full Text] [Related]

  • 6. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
    Sukalovic V, Ignjatovic D, Tovilovic G, Andric D, Shakib K, Kostic-Rajacic S, Soskic V.
    Bioorg Med Chem Lett; 2012 Jun 15; 22(12):3967-72. PubMed ID: 22607670
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
    Balle T, Perregaard J, Ramirez MT, Larsen AK, Søby KK, Liljefors T, Andersen K.
    J Med Chem; 2003 Jan 16; 46(2):265-83. PubMed ID: 12519065
    [Abstract] [Full Text] [Related]

  • 8. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM, Welge JA, Logue AD, Keck PE, Strakowski SM, McNamara RK.
    Prog Brain Res; 2008 Jan 16; 172():155-75. PubMed ID: 18772032
    [Abstract] [Full Text] [Related]

  • 9. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
    TenBrink RE, Bergh CL, Duncan JN, Harris DW, Huff RM, Lahti RA, Lawson CF, Lutzke BS, Martin IJ, Rees SA, Schlachter SK, Sih JC, Smith MW.
    J Med Chem; 1996 Jun 21; 39(13):2435-7. PubMed ID: 8691438
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents.
    Chandra Sekhar KV, Rao VS, Krishna MM.
    J Enzyme Inhib Med Chem; 2009 Jun 21; 24(3):871-5. PubMed ID: 18825551
    [Abstract] [Full Text] [Related]

  • 11. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J, Sukalović V, Andrić D, Kostić-Rajacić S, Soskić V, Roglić G.
    Arch Pharm (Weinheim); 2007 Sep 21; 340(9):456-65. PubMed ID: 17763374
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.
    Tomić M, Kundaković M, Butorović B, Janać B, Andrić D, Roglić G, Ignjatović D, Kostić-Rajacić S.
    Bioorg Med Chem Lett; 2004 Aug 16; 14(16):4263-6. PubMed ID: 15261283
    [Abstract] [Full Text] [Related]

  • 13. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Santagada V, Caliendo G.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2978-82. PubMed ID: 20347301
    [Abstract] [Full Text] [Related]

  • 14. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A, Arbus C, Nuss P, Garay RP, Neliat G, Hameg A.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):142-7. PubMed ID: 17936750
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
    Park CM, Kim SY, Park WK, Park NS, Seong CM.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3844-7. PubMed ID: 18602261
    [Abstract] [Full Text] [Related]

  • 16. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J, Yoo EA, Kim JY, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2008 May 15; 16(10):5405-12. PubMed ID: 18456500
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV, Rao VS, Deuther-Conrad W, Reddy AS, Brust P, Krishna Kumar MM.
    J Enzyme Inhib Med Chem; 2011 Aug 15; 26(4):561-8. PubMed ID: 21171898
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ, Parrish JC, Jensen NH, Kurrasch-Orbaugh DM, Marona-Lewicka D, Nichols DE.
    J Med Chem; 2003 Jul 31; 46(16):3526-35. PubMed ID: 12877591
    [Abstract] [Full Text] [Related]

  • 19. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
    Butini S, Gemma S, Campiani G, Franceschini S, Trotta F, Borriello M, Ceres N, Ros S, Coccone SS, Bernetti M, De Angelis M, Brindisi M, Nacci V, Fiorini I, Novellino E, Cagnotto A, Mennini T, Sandager-Nielsen K, Andreasen JT, Scheel-Kruger J, Mikkelsen JD, Fattorusso C.
    J Med Chem; 2009 Jan 08; 52(1):151-69. PubMed ID: 19072656
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, Tagashira R, Matsumoto K, Nishikawa H, Ueda Y, Toma S, Oki H, Tanno N, Saji I, Ito A, Ohno Y, Nakamura M.
    J Pharmacol Exp Ther; 2010 Jul 08; 334(1):171-81. PubMed ID: 20404009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.